Molekulargenetische Diagnostik
Praxis Dr. Mato Nagel

Makuladegeneration

Die Makuladegeneration ist eine erbliche Augenerkrankung die die Macula lutea des Auges betrifft und zur Erblindung führt.

Einteilung

Klinisch werden senile und früheinsetzende Formen sowie feuchte und trockene Makuladegenerationunterschieden.

Die genetische Diagnostik erlaubt eine pathogenetische Differenzierung entsprechend der zugrundeliegenden Mutationen.

Gliederung

Erbliche Augenerkrankungen und Sehstörungen
Fischaugen-Erkrankung
Hereditäres Glaucom
Knobloch-Syndrome 1
Makuladegeneration
Altersabhängige Makuladegeneration 01
APOE
ARMS2
C2
C3
CFH
CFHR1
CFHR3
KCNT2
Früheinsetzende Makuladegeneration
FBN2
Marles-Syndrom
Papillorenales Syndrom
Syndromische Microphthalmie 6
Usher-Syndrom

Referenzen:

1.

Lambooij AC et. al. (2003) Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration.

[^]
2.

Doyle SL et. al. (2012) NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components.

[^]
3.

Tarallo V et. al. (2012) DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88.

[^]
4.

Majewski J et. al. (2003) Age-related macular degeneration--a genome scan in extended families.

[^]
5.

Seddon JM et. al. (2003) A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions.

[^]
6.

Weeks DE et. al. (2004) Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

[^]
7.

Jakobsdottir J et. al. (2005) Susceptibility genes for age-related maculopathy on chromosome 10q26.

[^]
8.

Ratnapriya R et. al. (2014) Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration.

[^]
9.

Malek G et. al. (2005) Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

[^]
10.

None (1966) Dystrophy of the macula.

[^]
11.

Heiba IM et. al. (1994) Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study.

[^]
12.

Seddon JM et. al. (1997) Familial aggregation of age-related maculopathy.

[^]
13.

Allikmets R et. al. (1997) Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.

[^]
14.

Klein ML et. al. (1998) Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q.

[^]
15.

Smith RS et. al. (2000) The bst locus on mouse chromosome 16 is associated with age-related subretinal neovascularization.

[^]
16.

Weeks DE et. al. (2000) A full genome scan for age-related maculopathy.

[^]
17.

Beatty S et. al. () The role of oxidative stress in the pathogenesis of age-related macular degeneration.

[^]
18.

Yannuzzi LA et. al. (2001) Retinal angiomatous proliferation in age-related macular degeneration.

[^]
19.

Weeks DE et. al. (2001) Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regions.

[^]
20.

Dithmar S et. al. (2001) Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane.

[^]
21.

Krzystolik MG et. al. (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

[^]
22.

None (2002) Retinal angiomatous proliferation in age-related macular degeneration.

[^]
23.

Crabb JW et. al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.

[^]
24.

None (2002) New insights and new approaches toward the study of age-related macular degeneration.

[^]
25.

Malek G et. al. (2003) Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy.

[^]
26.

Cousins SW et. al. (2003) Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice.

[^]
27.

Jonasson F et. al. (2003) The prevalence of age-related maculopathy in iceland: Reykjavik eye study.

[^]
28.

Borrillo JL et. al. (2003) Surgical ablation of retinal angiomatous proliferation.

[^]
29.

Phipps JA et. al. (2003) Loss of cone function in age-related maculopathy.

[^]
30.

Klein R et. al. (2003) Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy.

[^]
31.

Danciger M et. al. (2003) A strong and highly significant QTL on chromosome 6 that protects the mouse from age-related retinal degeneration.

[^]
32.

Hahn P et. al. (2003) Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane.

[^]
33.

Heckenlively JR et. al. (2003) Mouse model of subretinal neovascularization with choroidal anastomosis.

[^]
34.

Schultz DW et. al. (2003) Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family.

[^]
35.

Espinosa-Heidmann DG et. al. (2004) Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E.

[^]
36.

Iyengar SK et. al. (2004) Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

[^]
37.

Axer-Siegel R et. al. (2004) Association of neovascular age-related macular degeneration and hyperhomocysteinemia.

[^]
38.

Scholl HP et. al. (2004) What is lost by digitizing stereoscopic fundus color slides for macular grading in age-related maculopathy and degeneration?

[^]
39.

Grisanti S et. al. (2004) Expression of endoglin in choroidal neovascularization.

[^]
40.

Jonas JB et. al. (2004) Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.

[^]
41.

Klein R et. al. (2004) The epidemiology of age-related macular degeneration.

[^]
42.

None (2004) Current concepts in the pathogenesis of age-related macular degeneration.

[^]
43.

Jonasson F et. al. (2005) 5-year incidence of age-related maculopathy in the Reykjavik Eye Study.

[^]
44.

Ethen CM et. al. (2005) Declines in arrestin and rhodopsin in the macula with progression of age-related macular degeneration.

[^]
45.

Goverdhan SV et. al. (2005) Association of HLA class I and class II polymorphisms with age-related macular degeneration.

[^]
46.

Postel EA et. al. (2005) Comparing age-related macular degeneration phenotype in probands from singleton and multiplex families.

[^]
47.

Dunaief JL et. al. (2005) Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload.

[^]
48.

Seddon JM et. al. (2005) Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.

[^]
49.

Schultz DW et. al. (2005) HEMICENTIN-1 (FIBULIN-6) and the 1q31 AMD locus in the context of complex disease: review and perspective.

[^]
50.

Thornton J et. al. (2005) Smoking and age-related macular degeneration: a review of association.

[^]
51.

Chowers I et. al. (2006) The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration.

[^]
52.

Imamura Y et. al. (2006) Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration.

[^]
53.

None (2006) Age-related macular degeneration.

[^]
54.

Nolan JM et. al. (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment.

[^]
55.

Tamer C et. al. (2007) Serum dehydroepiandrosterone sulphate level in age-related macular degeneration.

[^]
56.

Fisher SA et. al. (2007) Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD).

[^]
57.

Tan JS et. al. (2007) Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

[^]
58.

Decanini A et. al. (2007) Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration.

[^]
59.

Kim DH et. al. (2007) Strategies for silencing human disease using RNA interference.

[^]
60.

Gupta SK et. al. (2007) Prevalence of early and late age-related macular degeneration in a rural population in northern India: the INDEYE feasibility study.

[^]
61.

Boekhoorn SS et. al. (2007) Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder.

[^]
62.

Chakravarthy U et. al. (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study.

[^]
63.

Schaumberg DA et. al. (2007) High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women.

[^]
64.

Tan JS et. al. (2007) Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.

[^]
65.

Bhosale P et. al. (2007) Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula.

[^]
66.

Kamei M et. al. (2007) Scavenger receptors for oxidized lipoprotein in age-related macular degeneration.

[^]
67.

Sivaprasad S et. al. (2007) Estimation of systemic complement C3 activity in age-related macular degeneration.

[^]
68.

De S et. al. (2007) Human retinal pigment epithelium cell changes and expression of alphaB-crystallin: a biomarker for retinal pigment epithelium cell change in age-related macular degeneration.

[^]
69.

Maruko I et. al. (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

[^]
70.

Li C et. al. (2007) Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation.

[^]
71.

Thompson CL et. al. (2007) Genetics of pigment changes and geographic atrophy.

[^]
72.

Lotery A et. al. (2007) Progress in defining the molecular biology of age related macular degeneration.

[^]
73.

Kleinman ME et. al. (2008) Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.

[^]
74.

Yang Z et. al. (2008) Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.

[^]
75.

Fujihara M et. al. (2009) A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD.

[^]
76.

Edwards AO et. al. (2009) Geographic atrophy in age-related macular degeneration and TLR3.

[^]
77.

Allikmets R et. al. (2009) Geographic atrophy in age-related macular degeneration and TLR3.

[^]
78.

Takeda A et. al. (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy.

[^]
79.

Kondo N et. al. (2010) Additional evidence to support the role of a common variant near the complement factor I gene in susceptibility to age-related macular degeneration.

[^]
80.

Kaneko H et. al. (2011) DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration.

[^]
81.

Arakawa S et. al. (2011) Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population.

[^]
82.

Fowler BJ et. al. (2014) Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity.

[^]
83.

Pras E et. al. (2015) Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration.

[^]
84.

Pang CE et. al. (2015) The Onion Sign in Neovascular Age-Related Macular Degeneration Represents Cholesterol Crystals.

[^]
85.

Joachim N et. al. (2015) The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.

[^]